V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20225620 | 20085167 | 1.6 | 52.1 | Neo-adjuvant (N) | 2018-05-06 | 2018-05-08 | Enzalutamide | N | N | ATEZOLIZUMAB + BEVACIZUMAB | 100602551 |
| 20225622 | 20085168 | 1.65 | null | null | 2017-09-17 | 2017-09-28 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100042115 |
| 20225623 | 20085169 | 1.62 | 59.2 | Palliative (P) | 2016-08-26 | 2016-08-27 | Enzalutamide | 2 | N | TRASTUZUMAB | 100598625 |
| 20225625 | 20085170 | 1.8 | 68 | Palliative (P) | 2018-01-31 | 2018-03-01 | Enzalutamide | 02 | N | TRASTUZUMAB | 101690570 |
| 20225627 | 20085171 | 1.63 | 82.7 | Palliative (P) | 2018-06-25 | 2018-07-09 | Enzalutamide | 2 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101655670 |
| 20225629 | 20085172 | null | 68.4 | Neo-adjuvant (N) | 2018-09-14 | 2018-09-14 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100762089 |
| 20225650 | 20085173 | 1.7 | 86 | Curative (C) | 2016-06-09 | 2016-06-15 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100207404 |
| 20225651 | 20085174 | 1.62 | 36.8 | Neo-adjuvant (N) | 2019-02-27 | 2019-03-06 | ECF | 2 | N | ECF | 101604183 |
| 20225655 | 20085175 | 1.7 | 54.15 | Neo-adjuvant (N) | 2019-09-04 | 2019-09-04 | Capecitabine + Cisplatin + RT | null | N | TRASTUZUMAB | 101436275 |
| 20225664 | 20085176 | 1.8 | 91.3 | Palliative (P) | 2016-04-28 | 2016-05-27 | Cetuximab 14 day | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101555581 |
| 20225665 | 20085177 | 1.61 | 81 | Palliative (P) | 2018-07-15 | 2018-07-17 | Enzalutamide | N | N | CISPLATIN | 100831874 |
| 20225675 | 20085178 | 1.7 | null | 4 | 2018-03-29 | 2018-03-30 | Enzalutamide | 02 | null | SCALOP-2 TRIAL | 100381180 |
| 20225676 | 20085179 | 1.56 | 90.95 | Palliative (P) | 2018-05-16 | 2018-05-16 | Enzalutamide | 02 | N | TRASTUZUMAB | 100345172 |
| 20225677 | 20085180 | 1.83 | 91 | null | 2017-07-10 | 2017-07-16 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101350299 |
| 20225681 | 20085181 | 1.72 | 92.3 | Palliative (P) | 2019-05-25 | 2019-06-05 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101240428 |
| 20225683 | 20085182 | 1.79 | 92 | Palliative (P) | 2018-12-21 | 2018-12-30 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101356697 |
| 20225684 | 20085183 | 1.8 | null | Palliative (P) | 2018-01-22 | 2018-01-25 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101353365 |
| 20225691 | 20085184 | 1.73 | 71 | Palliative (P) | 2016-10-11 | 2016-10-13 | Enzalutamide | N | N | SCALOP-2 TRIAL | 101806474 |
| 20225695 | 20085185 | 1.65 | 63.4 | Curative (C) | 2017-10-17 | 2017-10-27 | Enzalutamide | 02 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100946545 |
| 20225696 | 20085186 | 1.73 | 82.1 | Adjuvant (A) | 2014-02-16 | 2020-03-05 | Enzalutamide | 02 | N | CETUXIMAB | 100090435 |
| 20225697 | 20085187 | 1.52 | 50.7 | Curative (C) | 2016-12-28 | 2017-01-11 | Enzalutamide | 02 | N | OCTREOTIDE | 101662795 |
| 20225704 | 20085188 | 1.82 | 72.1 | Neo-adjuvant (N) | 2019-02-20 | 2019-03-27 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100339703 |
| 20225705 | 20085189 | 1.6 | 60.2 | Palliative (P) | null | 2017-08-09 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101358913 |
| 20225715 | 20085190 | 1.78 | 75.6 | Palliative (P) | 2016-06-12 | 2016-06-21 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100852714 |
| 20000171 | 20085192 | 1.61 | 60.2 | Curative (C) | 2017-04-20 | 2017-04-28 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101043846 |
| 20000416 | 20085194 | 1.5 | 69.4 | Curative (C) | 2021-09-10 | 2021-09-24 | Carboplatin AUC 2 - 5 | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 100475507 |
| 20000479 | 20085196 | 0 | 88.9 | Palliative (P) | 2018-06-30 | 2018-07-14 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101134221 |
| 20000492 | 20085197 | 1.8 | null | Palliative (P) | 2018-11-24 | 2018-12-04 | Enzalutamide | N | N | CAPECITABINE + CISPLATIN + RT | 100063602 |
| 20000621 | 20085199 | 0.75 | 76 | Neo-adjuvant (N) | 2017-10-28 | 2017-10-29 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100809768 |
| 20000632 | 20085200 | 1.54 | 51.6 | Palliative (P) | 2018-08-12 | 2018-08-12 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101129797 |
| 20000735 | 20085201 | 1.78 | 80.65 | Curative (C) | 2018-11-30 | 2018-11-30 | TRASTUZUMAB | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100854971 |
| 20000743 | 20085202 | 1.74 | 90.4 | Palliative (P) | 2021-01-31 | 2021-03-05 | ECF | 02 | N | OCTREOTIDE | 101480809 |
| 20000846 | 20085203 | 0 | 83 | Palliative (P) | 2022-03-18 | 2022-03-30 | CARBOPLATIN + GEMCITABINE | 02 | Y | CARBOPLATIN + GEMCITABINE | 100121567 |
| 20000876 | 20085204 | 1.79 | 84 | null | 2019-10-28 | 2019-11-24 | OCTREOTIDE | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101109616 |
| 20000931 | 20085205 | 1.66 | 109 | Curative (C) | 2016-04-12 | 2016-04-26 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100952502 |
| 20001010 | 20085206 | 1.73 | 102.8 | Curative (C) | 2018-01-05 | 2018-01-06 | Capecitabine + Cisplatin + RT | N | Y | CAPECITABINE + CISPLATIN + RT | 101744577 |
| 20001083 | 20085207 | 1.74 | 90.6 | Palliative (P) | 2020-02-09 | 2020-02-23 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100616471 |
| 20001145 | 20085208 | 1.7 | null | Palliative (P) | 2019-08-18 | 2019-08-18 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100989453 |
| 20001160 | 20085209 | 1.7 | 89 | Neo-adjuvant (N) | 2018-04-26 | 2018-05-09 | Enzalutamide | null | N | TRASTUZUMAB | 101290690 |
| 20001263 | 20085211 | 1.74 | null | Palliative (P) | 2019-03-26 | 2019-03-26 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100913040 |
| 20001305 | 20085212 | 1.61 | 76.6 | Neo-adjuvant (N) | 2020-01-17 | 2020-01-17 | Cetuximab 14 day | 02 | N | ENZALUTAMIDE | 100746434 |
| 20001315 | 20085213 | null | 77.2 | Adjuvant (A) | 2017-05-17 | 2017-05-23 | Enzalutamide | 02 | N | CETUXIMAB | 101739285 |
| 20001464 | 20085214 | 1.88 | 59.8 | Palliative (P) | null | 2017-10-29 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101462799 |
| 20001546 | 20085215 | null | 71.9 | null | 2020-04-03 | 2020-04-03 | Enzalutamide | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101370138 |
| 20001553 | 20085216 | 1.54 | 62.6 | Palliative (P) | null | 2019-05-03 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101030184 |
| 20001565 | 20085217 | 1.69 | null | Curative (C) | 2018-01-14 | 2018-01-15 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101110031 |
| 20001568 | 20085218 | 1.88 | 96.4 | Curative (C) | 2019-10-08 | 2019-10-11 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100471597 |
| 20001655 | 20085219 | 1.87 | 92 | Curative (C) | 2018-09-12 | 2018-10-06 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100121733 |
| 20001717 | 20085220 | 1.64 | null | Palliative (P) | 2019-07-02 | 2019-07-22 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101417641 |
| 20001735 | 20085221 | 0 | 90 | Palliative (P) | 2022-02-04 | 2022-02-04 | Cetuximab 14 day | 02 | null | ENZALUTAMIDE | 101112231 |